Edwards Lifesciences Up Over 6%, on Pace for Largest Percent Increase Since November 2020 — Data Talk
Edwards Lifesciences Corporation (EW) is currently at $78.83, up $4.93 or 6.67%
--Would be highest close since Aug. 15, 2023, when it closed at $79.86
--On pace for largest percent increase since Nov. 9, 2020, when it rose 7.65%
--Currently up three of the past five days
--Up 3.38% month-to-date; on pace for best month since Dec. 2023, when it rose 12.61%
--Up 3.38% year-to-date
--Down 39.68% from its all-time closing high of $130.68 on Dec. 30, 2021
--Down 3.25% from 52 weeks ago (Feb. 1, 2023), when it closed at $81.48
--Down 16.43% from its 52-week closing high of $94.33 on June 30, 2023
--Up 27.74% from its 52-week closing low of $61.71 on Oct. 27, 2023
--Traded as high as $79.26; highest intraday level since Aug. 16, 2023, when it hit $79.98
--Up 7.25% at today's intraday high; largest intraday percent increase since Nov. 9, 2020, when it rose as much as 10%
--Second best performer in the S&P 500 today
All data as of 10:18:18 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
January 31, 2024 10:36 ET (15:36 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits